Greenhaven Road Investment Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Greenhaven Road Investment Management's CLBT Position: Q2 2026 in Review
Greenhaven Road Investment Management reduced its Cellebrite (CLBT) stake by 18% in Q2 2026, selling an estimated $3.64M and leaving 1,260,039 shares worth $18.4M. The position accounts for 11.94% of the portfolio, ranked #2.
Greenhaven Road Investment Management first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. The position peaked at $43.5M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Greenhaven Road Investment Management held 1,260,039 shares of Cellebrite worth $18.4M as of Q2 2026.
- Greenhaven Road Investment Management sold 275,212 Cellebrite shares in Q2 2026, an estimated $3.64M.
- Cellebrite made up 11.94% of Greenhaven Road Investment Management's portfolio in Q2 2026, its #2 holding.
- Greenhaven Road Investment Management first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
- Greenhaven Road Investment Management's Cellebrite position peaked at $43.5M in Q4 2024.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Greenhaven Road Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.